[Polynuclear neutrophil anti-cytoplasmic antibodies or ANCA: current aspects].
Noel
L H
LH
C.H.U, Hédi Chaker, 3029 Sfax, Tunisie.
Hachicha
J
J
Ayadi
H
H
Ben Hmida
M
M
Jlidi
R
R
Jarraya
A
A
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis* / Q000502:physiology; D000974:Antibodies, Antinuclear / Q000032:analysis; D015267:Churg-Strauss Syndrome / Q000175:diagnosis; D004797:Enzyme-Linked Immunosorbent Assay; D019084:Fluorescent Antibody Technique, Indirect; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis; D006801:Humans; D010488:Polyarteritis Nodosa / Q000175:diagnosis; D017445:Skin Diseases, Vascular / Q000175:diagnosis; D014652:Vascular Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D014657:Vasculitis / Q000175:diagnosis
D019268:Antibodies, Antineutrophil Cytoplasmic; D000974:Antibodies, Antinuclear
Les anticorps anti-cytoplasme des polynucléaires neutrophiles ou "ANCA": aspects actuels.